XXIII World Congress of Asthma

About XXIII World Congress of Asthma

Significant achievements have been accomplished in the last few years to better understanding what is asthma, how it should be assessed in regard to control and severity and what is its optimal therapy. Unfortunately these improvements in our understanding of the disease have not always translated into better asthma management.

The 2016 World Congress on Asthma in Madrid will review the key findings from recent research on both adult and pediatric Asthma and how knowledge translation methods have evolved to better integrate research findings into care.

The origins and determinants of Asthma, triggers and inducers, the new insight gained on the role of allergy, environmental and biodiversity changes, workplace hazards, respiratory infections andvarious aspects of assessment of the disease are among the topics that will be covered by world experts. The role of phenotyping/endotyping Asthma, particularly when severe, and new therapeutic current and future advances will be covered.

A significant part of the meeting will be devoted to practical workshops on asthma testing and treatment delivery, as we'll as the integration of practice tools into day-to-day care. Sessions will discuss how to optimize the multidisciplinary approach to asthma management.

WCA brings together specialists, physicians, and healthcare professionals from all over the world to share valuable scientific knowledge on asthma, ranging from diagnostic and therapeutic tools and techniques to leading-edge research. WCA has been very popular resulting in highly successful well attended congresses with outstanding state-of-the-art scientific programs. The 23rd World Congress of Asthma - WCA-2016 will not be an exception.